<?xml version="1.0" encoding="UTF-8"?>
<ref id="B261-vaccines-08-00036">
 <label>261.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Feuring-Buske</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gerhard</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Cashman</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Humphries</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Eaves</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Hogge</surname>
    <given-names>D.E.</given-names>
   </name>
  </person-group>
  <article-title>Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors</article-title>
  <source>Leukemia</source>
  <year>2003</year>
  <volume>17</volume>
  <fpage>760</fpage>
  <lpage>763</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.leu.2402882</pub-id>
  <pub-id pub-id-type="pmid">12682634</pub-id>
 </element-citation>
</ref>
